United States Appears To Walk Back on Threats To Withdraw from World Health Organization – Calls For Countries To Adopt ‘Roadmap for Reform’ 05/10/2020 Elaine Ruth Fletcher The United States appears to be walking back on threats to withdraw from the World Health Organization – just as US President Donald Trump is reported to be recovering from a bout with COVID-19 in Washington, DC. Speaking at the first formal meeting of WHO’s Executive Board governing body to be convened since May, US […] Continue reading -> COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> WHO Director General Wishes President Donald Trump Speedy Recovery From COVID-19 – As US Presidential Campaign Enters Uncharted Waters 02/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin WHO Director General Dr Tedros Adhanom Ghebreyesus joined the chorus of world leaders wishing United States President Donald Trump and his wife a speedy recovery from COVID-19 – while the US presidential campaign entered uncharted waters, with the cancellation of campaign rallies and fears that other White House Staff and political allies who had accompanied […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Infodemic Poses Serious Risk to COVID-19 Response, Warn Experts At A United Nations General Assembly Event 28/09/2020 Madeleine Hoecklin The ‘infodemic’ is one of the “most concerning” governance challenges of our time, undermining trust in science in the midst of the pandemic, and threatening people’s physical and mental health, warned United Nations Development Program (UNDP) Administrator Achim Steimer. While the overabundance of misinformation – or ‘infodemic – is not new, it has blown out […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> WHO Director General Wishes President Donald Trump Speedy Recovery From COVID-19 – As US Presidential Campaign Enters Uncharted Waters 02/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin WHO Director General Dr Tedros Adhanom Ghebreyesus joined the chorus of world leaders wishing United States President Donald Trump and his wife a speedy recovery from COVID-19 – while the US presidential campaign entered uncharted waters, with the cancellation of campaign rallies and fears that other White House Staff and political allies who had accompanied […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Infodemic Poses Serious Risk to COVID-19 Response, Warn Experts At A United Nations General Assembly Event 28/09/2020 Madeleine Hoecklin The ‘infodemic’ is one of the “most concerning” governance challenges of our time, undermining trust in science in the midst of the pandemic, and threatening people’s physical and mental health, warned United Nations Development Program (UNDP) Administrator Achim Steimer. While the overabundance of misinformation – or ‘infodemic – is not new, it has blown out […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Director General Wishes President Donald Trump Speedy Recovery From COVID-19 – As US Presidential Campaign Enters Uncharted Waters 02/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin WHO Director General Dr Tedros Adhanom Ghebreyesus joined the chorus of world leaders wishing United States President Donald Trump and his wife a speedy recovery from COVID-19 – while the US presidential campaign entered uncharted waters, with the cancellation of campaign rallies and fears that other White House Staff and political allies who had accompanied […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Infodemic Poses Serious Risk to COVID-19 Response, Warn Experts At A United Nations General Assembly Event 28/09/2020 Madeleine Hoecklin The ‘infodemic’ is one of the “most concerning” governance challenges of our time, undermining trust in science in the midst of the pandemic, and threatening people’s physical and mental health, warned United Nations Development Program (UNDP) Administrator Achim Steimer. While the overabundance of misinformation – or ‘infodemic – is not new, it has blown out […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Infodemic Poses Serious Risk to COVID-19 Response, Warn Experts At A United Nations General Assembly Event 28/09/2020 Madeleine Hoecklin The ‘infodemic’ is one of the “most concerning” governance challenges of our time, undermining trust in science in the midst of the pandemic, and threatening people’s physical and mental health, warned United Nations Development Program (UNDP) Administrator Achim Steimer. While the overabundance of misinformation – or ‘infodemic – is not new, it has blown out […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Infodemic Poses Serious Risk to COVID-19 Response, Warn Experts At A United Nations General Assembly Event 28/09/2020 Madeleine Hoecklin The ‘infodemic’ is one of the “most concerning” governance challenges of our time, undermining trust in science in the midst of the pandemic, and threatening people’s physical and mental health, warned United Nations Development Program (UNDP) Administrator Achim Steimer. While the overabundance of misinformation – or ‘infodemic – is not new, it has blown out […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Can Uganda Contain Its COVID-19 Infection Spike? Reflections Of An Emergency Room Doctor 26/08/2020 Samson Wamani Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts